SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-23-012317
Filing Date
2023-03-17
Accepted
2023-03-17 16:22:20
Documents
5
Effectiveness Date
2023-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10049904_s8.htm S-8 80122
2 EXHIBIT 5.1 brhc10049904_ex5-1.htm EX-5.1 10620
3 EXHIBIT 23.1 brhc10049904_ex23-1.htm EX-23.1 1889
4 EXHIBIT 107.1 brhc10049904_ex107-1.htm EX-FILING FEES 18332
5 image0.jpg GRAPHIC 10024
  Complete submission text file 0001140361-23-012317.txt   125864
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270655 | Film No.: 23742920
SIC: 2834 Pharmaceutical Preparations